Start-up to develop new treatment for heart failure
Our Department exploits their academic findings towards rational therapy development for genetic and acquired forms of heart failure in the Dutch spin-off company Mirabilis Therapeutics BV that was founded in 2015.
Mirabilis Therapeutics BV is a drug development company dedicated to the discovery and development of innovative products in the field of cardiovascular diseases.
For more information on Mirabilis Therapeutics BV, please visit: www.mirabilis-therapeutics.com
Also read
-
Maastricht University received grants for three of the ten research projects starting in the National Growth Fund program Circular Plastics NL.
-
"I am proud that our new Circular Plastics group published its first completely in-house research," Kim Ragaert says. She founded the research group three years ago, when she moved to Maastricht. Her work has laid the foundations for many innovations in the field of plastic recycling, and she is...
-
Programming quantum computers, like the quantum computer itself, is still in its early stages. Quantum computing researchers tend to be physicists, mathematicians, or computer scientists who have a special interest in the mathematical framework of quantum mechanics.
